MagForce company profile

Business Description

MagForce AG is a leading medical device company in the field of nanomedicine focused on oncology. The Group's proprietary NanoTherm(R) therapy enables the targeted treatment of solid tumors through the intratumoral generation of heat via activation of superparamagnetic nanoparticles. NanoTherm(R), NanoPlan(R), and NanoActivator(R) are components of the therapy and have received EU-wide regulatory approval as medical devices for the treatment of brain tumors. MagForce, NanoTherm, NanoPlan, and NanoActivator are trademarks of MagForce AG in selected countries.

Initial listingSeptember 20, 2007
Accounting standardsGerman Commercial Code ("HGB")
Fiscal year endDecember 31
Executive BoardDr. Ben J. Lipps, Prof. Hoda Tawfik, Christian von Volkmann
Supervisory BoardNorbert Neef (Chairman), Stephan Jakober, Dr. Wiebke Rösler
Registered OfficeMax-Planck-Str 3, 12489 Berlin, Germany

TRADING Information

ISINDE000A0HGQF5
Stock ExchangeXetra/Frankfurt
German Securities Identification Number (WKN)A0HGQF
Ticker SymbolMF6
Market SegmentScale
Stock ClassNo-par-value shares
Share Capital€ 25,622,711
Total Number of Shares25,622,711 shares
SpecialistSteubing AG
Applying & Supervising Capital Markets Partner, Designated SponsorHauck & Aufhäuser